The existing therapies for improving AD symptoms work on a specific target, for example, acetylcholine esterase inhibitors (Donepezil, Galantamine, and Rivastigmine), anti-amyloid antibodies (Aduhelm), and NMDA receptor antagonists (Memantine). Here, ACHE is linked to Alzheimer disease.